Syndax Pharmaceuticals (SNDX) Debt Ratio (2015 - 2026)

Syndax Pharmaceuticals' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.47 for Q4 2024.

• In Q4 2024, Debt Ratio changed N/A year-over-year to 0.47; the TTM figure through Dec 2024 stood at 0.47 (changed N/A YoY), while the FY2024 annual figure was 0.47, changed N/A from the prior year.
• Debt Ratio for Q4 2024 stood at 0.47, up from 0.05 in the prior quarter.
• The five-year high for Debt Ratio was 0.47 in Q4 2024, with the low at 0.04 in Q4 2021.
• The 4-year median for Debt Ratio is 0.08 (2021), against an average of 0.12.
• Peak annual rise in Debt Ratio reached 23.37% in 2021, while the deepest fall reached 61.56% in 2021.
• Syndax Pharmaceuticals' Debt Ratio stood at 0.07 in 2020, then sank by 33.89% to 0.04 in 2021, then advanced by 12.36% to 0.05 in 2022, then jumped by 853.76% to 0.47 in 2024.
• Business Quant data shows SNDX's Debt Ratio at 0.47 in Q4 2024, 0.05 in Q2 2022, and 0.05 in Q1 2022.